We are live on ! Find out more
AVM

Arch Venture Management Portfolio holdings

AUM $677M
1-Year Est. Return 322.07%
This Fund
S&P 500
This Quarter Est. Return
+47.04%
1 Year Est. Return
+322.07%
3 Year Est. Return
+208.96%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$29.7M
AUM Growth
-$29.5M
Cap. Flow
-$47.8M
Cap. Flow %
-160.79%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$23.9M
2
IOTS
Adesto Technologies Corp
IOTS
+$21M
3
KURA icon
Kura Oncology
KURA
+$2.88M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
$15.7M 52.68%
2,618,351
– –
CHMA
2
DELISTED
Chiasma, Inc. Common Stock
CHMA
$6.44M 21.66%
1,196,776
– –
SYRS
3
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4.26M 14.35%
40,000
-266,382
-87% -$23.9M
KURA icon
4
Kura Oncology
KURA
$916M
$3.36M 11.31%
206,307
-200,000
-49% -$2.88M
IOTS
5
DELISTED
Adesto Technologies Corp
IOTS
– –
-1,876,511
Closed -$21M

Similar funds

NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $676M AUM 34.17% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
DLIC
Daido Life Insurance Company Osaka, Japan $678M AUM 16.09% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Arch Venture Management's Q2 2020 Portfolio in Review

As of Q2 2020, Arch Venture Management held 5 positions worth $29.7M, down 50% from $59.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Arch Venture Management withdrew a net $47.8M in Q2 2020, closing 1 position and reducing 2 holdings. Its most notable exit was Adesto Technologies Corp, an estimated $21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 65% a quarter earlier, followed by Technology.

  • Arch Venture Management's biggest Q2 2020 reduction was Syros Pharmaceuticals, Inc. Common Stock, cutting an estimated $23.9M.
  • Arch Venture Management fully exited Adesto Technologies Corp in Q2 2020, selling an estimated $21M.
  • Arch Venture Management's ten largest holdings make up 100% of its $29.7M portfolio in Q2 2020.
  • Arch Venture Management opened 0 new positions and closed 1 in Q2 2020.
  • Arch Venture Management's portfolio value fell 50% quarter-over-quarter to $29.7M.

Based on Arch Venture Management's 13F filing for Q2 2020, filed 12 Aug 2020.